Use of sibutramine analogues to lower lipid levels

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/135 (2006.01) A61K 31/137 (2006.01)

Patent

CA 2266378

A compound of formula (I) or a pharmaceutically acceptable salt thereof in which R1 and R2 are independently H or methyl (for example N,N-dimethyl-1-(1-(4-chlorophenyl)cyclobutyl]-3-methylbutyl amine hydrochloride optionally in the form of its monohydrate) is used for lowering lipid levels and/or increasing the HDL : LDL cholesterol ratio in humans, for example in humans having hyperlipidaemia, hypercholesterolaemia or hypertriglyceridaemia.

L'invention concerne un composé présentant la formule (I) ou un sel pharmaceutiquement acceptable de ce dernier, dans lequel R1 et R2 sont indépendamment H ou méthyle (par exemple, de l'hydrochlorure d'amine N,N-diméthyle-1-(1-(4-chlorophényle)cyclobutyl)-3-méthylbutyl éventuellement sous la forme de son monohydrate). Ce composé est utilisé pour abaisser le taux de lipides et/ou augmenter le rapport de cholestérol HDL/LDL chez l'homme, par exemple, chez l'homme souffrant d'hyperlipidémie, hypercholestérolémie ou hypertriglycéridémie.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of sibutramine analogues to lower lipid levels does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of sibutramine analogues to lower lipid levels, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of sibutramine analogues to lower lipid levels will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1649247

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.